These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15118638)

  • 1. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study.
    Barda G; Menczer J; Chetrit A; Lubin F; Beck D; Piura B; Glezerman M; Modan B; Sadetzki S;
    Am J Obstet Gynecol; 2004 Apr; 190(4):1039-45. PubMed ID: 15118638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
    Chetrit A; Hirsh-Yechezkel G; Ben-David Y; Lubin F; Friedman E; Sadetzki S
    J Clin Oncol; 2008 Jan; 26(1):20-5. PubMed ID: 18165636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
    Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS
    Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary peritoneal carcinoma--Uterine involvement and hysterectomy.
    Menczer J; Chetrit A; Barda G; Lubin F; Fishman A; Dgani R; Modan B; Sadetzki S;
    Gynecol Oncol; 2006 Mar; 100(3):565-9. PubMed ID: 16249019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
    Davidson B; Baekelandt M; Shih IeM
    Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
    Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
    Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
    Choi CH; Kim TJ; Kim WY; Ahn GH; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2007 Jun; 105(3):762-8. PubMed ID: 17383715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
    Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA
    Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade serous primary peritoneal carcinoma.
    Schmeler KM; Sun CC; Malpica A; Deavers MT; Bodurka DC; Gershenson DM
    Gynecol Oncol; 2011 Jun; 121(3):482-6. PubMed ID: 21397305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
    Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
    Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
    Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer.
    Halperin R; Zehavi S; Langer R; Hadas E; Bukovsky I; Schneider D
    Int J Gynecol Cancer; 2001; 11(5):403-8. PubMed ID: 11737473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical and pathological characteristics of epithelial ovarian carcinoma in patients with age under 40].
    Wen H; Sun W; Guo Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):548-51. PubMed ID: 9639757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of low-grade serous ovarian cancer.
    Plaxe SC
    Am J Obstet Gynecol; 2008 Apr; 198(4):459.e1-8; discussion 459.e8-9. PubMed ID: 18395040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
    Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
    Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.